Business review P06P53 Governance and remuneration P54P90 Financial statements P91P182 Shareholder information P183P204 91 Financial statements The financial statements Directors statement of responsibilities 92 provide a summary of the Independent Auditors report 93 Groups financial performance Financial statements throughout 2009 and its position Consolidated income statement 94 Consolidated statement of as at 31st December 2009.
The comprehensive income 94 consolidated financial statements Consolidated balance sheet 96 Consolidated statement of changes are prepared in accordance with in equity 97 the IFRS as adopted by the Consolidated cash flow statement 98 European Union and also IFRS Notes to the financial statements as issued by the International 1.
Presentation of the financial statements 99 2.
Accounting principles and policies 100 Accounting Standards Board.
Key accounting judgements and estimates 104 4.
Finance income 113 The consolidated financial statements present the 12.
Finance costs 114 profit and cash flow for the year and the balance 13.
Associates and joint ventures 114 sheet position at the end of the year.
Earnings per share 117 Notes to the financial statements 16.
Property, plant and equipment 118 The notes to the financial statements provide 18.
Goodwill 120 supporting analyses to the primary statements.
Investments in associates and joint ventures 125 Financial statements of GlaxoSmithKline plc 21.
Other investments 126 The financial statements of GlaxoSmithKline plc 22.
Other non-current assets 126 provide information on the company and are 23.
Inventories 126 prepared under UK GAAP.
Pensions and other post-employment benefits 128 29.
Share capital and share premium account 140 34.
Adjustments reconciling profit after tax to operating cash flows 142 37.
Reconciliation of net cash flow to movement in net debt 143 38.
Financial instruments and related disclosures 152 42.
Legal proceedings 169 Financial statements of GlaxoSmithKline plc, prepared under UK GAAP 177 GSK Annual Report 2009
